INDIGO Biosciences
Dr. Bruce A. Sherf joined The Company in 2008 as the Chief Technology Officer. Dr. Sherf, who has worked in the biotechnology industry since 1994, has particular expertise in cell-based reporter assay design and optimization, product development, and high-throughput screening applications for drug discovery. As CTO, he oversees INDIGO Biosciences’ product development, manufacturing, and technology transfer initiatives, as well as directing all Contract Services-related activities.
This person is not in any offices
INDIGO Biosciences
INDIGO Biosciences offers products and services focused on nuclear receptors, which comprise of therapeutic drug targets.